4.7 Article

Dissecting Disease Inheritance Modes in a Three-Dimensional Protein Network Challenges the Guilt-by-Association Principle

Journal

AMERICAN JOURNAL OF HUMAN GENETICS
Volume 93, Issue 1, Pages 78-89

Publisher

CELL PRESS
DOI: 10.1016/j.ajhg.2013.05.022

Keywords

-

Funding

  1. National Institutes of Health [R01 GM104424, R01 CA167824, R01 HG003229]
  2. Weill Cornell Medical College Clinical and Translational Science Center Pilot Award
  3. Cornell University Seed Grant
  4. Cornell Presidential Life Sciences Fellowship
  5. Tata Graduate Fellowship

Ask authors/readers for more resources

To better understand different molecular mechanisms by which mutations lead to various human diseases, we classified 82,833 disease-associated mutations according to their inheritance modes (recessive versus dominant) and molecular types (in-frame [missense point mutations and in-frame indels] versus truncating [nonsense mutations and frameshift indels]) and systematically examined the effects of different classes of disease mutations in a three-dimensional protein interactome network with the atomic-resolution interface resolved for each interaction. We found that although recessive mutations affecting the interaction interface of two interacting proteins tend to cause the same disease, this widely accepted guilt-by-association principle does not apply to dominant mutations. Furthermore, recessive truncating mutations in regions encoding the same interface are much more likely to cause the same disease, even for interfaces close to the N terminus of the protein. Conversely, dominant truncating mutations tend to be enriched in regions encoding areas between interfaces. These results suggest that a significant fraction of truncating mutations can generate functional protein products. For example, TRIM27, a known cancer-associated protein, interacts with three proteins (MID2, TRIM42, and SIRPA) through two different interfaces. A dominant truncating mutation (c.1024delT [p.Tyr342Thrfs*30]) associated with ovarian carcinoma is located between the regions encoding the two interfaces; the altered protein retains its interaction with MID2 and TRIM42 through the first interface but loses its interaction with SIRPA through the second interface. Our findings will help clarify the molecular mechanisms of thousands of disease-associated genes and their tens of thousands of mutations, especially for those carrying truncating mutations, often erroneously considered knockout alleles.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available